We only have this paper's title and publication details.
Read it at the sourceEvaluates outpatient venetoclax with azacitidine or decitabine in acute myeloid leukemia, highlighting feasibility outside inpatient settings.
No takes yet. Share an insight, caveat, or question.
Manda et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: